OraSure Technologies to Present at the Jefferies 2020 Healthcare Conference
BETHLEHEM, Pa., May 26, 2020 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic […]
Radware Helps HT Media Protect Its News and Photographic Archives From DDoS Attacks
MAHWAH, N.J., May 26, 2020 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a leading provider of cyber security and application delivery […]
Mesoblast to Host Analyst Call on Financial Results for Period Ended March 31, 2020
NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, […]
Allot Launches BusinessSecure, a New Solution for Telcos to Protect Their Business Customers from Cyberattacks
Hod Hasharon, Israel, May 26, 2020 (GLOBE NEWSWIRE) — Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT), a leading global provider of […]
36Kr Holdings Inc. Reports First Quarter 2020 Unaudited Financial Results
BEIJING, May 26, 2020 (GLOBE NEWSWIRE) — 36Kr Holdings Inc. (“36Kr” or the “Company” or “We”) (NASDAQ: KRKR), a prominent […]
Viomi Technology Co., Ltd Reports First Quarter 2020 Unaudited Financial Results
GUANGZHOU, China, May 26, 2020 (GLOBE NEWSWIRE) — Viomi Technology Co., Ltd (“Viomi” or the “Company”) (NASDAQ: VIOT), a leading IoT @ […]
Chi-Med and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of Surufatinib and Fruquintinib with Tislelizumab
– Collaboration to explore multiple solid tumor cancer indications –– Initial development focused on multi-cohort trials in the U.S., Europe, China […]
argenx Announces Positive Topline Results from Phase 3 ADAPT Trial of Efgartigimod in Patients with Generalized Myasthenia Gravis
Regulated information – Inside informationTrial met primary endpoint (p ˂0.0001) Well-tolerated; safety profile comparable to placebo Biologics License Application on track to […]
Celyad Announces June 2020 Conference Schedule
MONT-SAINT-GUIBERT, Belgium, May 26, 2020 (GLOBE NEWSWIRE) — Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company […]
Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
First participants enrolled in Phase 1 portion of clinical trial of NVX‑CoV2373Preliminary immunogenicity and safety results expected in July 2020Phase […]
